Immatics N.V.

IMTX chart

Immatics N.V. news

• Can Immatics N.V. (NASDAQ:IMTX) Overcome Its Latest Financial Setback?

  Kalkine Media · Oct 26, 8:01 PM EDT

• Immatics N.V. (IMTX) stock price, news, quote and history

  Yahoo Finance UK · Oct 26, 2:46 PM EDT

• Form 6-K Immatics N.V. For: Oct 24

  StreetInsider · Oct 26, 7:32 AM EDT

• Immatics (IMTX) Stock Dropped, So What Is Behind The Fresh Attention?

  Simply Wall Street · Oct 25, 1:44 PM EDT

• Should Updated Trial Results Require Action From Immatics (IMTX) Investors?

  Yahoo Finance · Oct 24, 11:20 PM EDT

• Immatics N.V. Presents Updated Clinical Trial Data from Ongoing Phase 1B Study with IMA402 PRAME Bispecific and Phase 1 Study with IMA203CD8 PRAME Cell Therapy

  www.marketscreener.com · Oct 24, 3:35 AM EDT

• Immatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meeting

  Yahoo Finance · Oct 24, 2:30 AM EDT

• One-time cell therapy at clinically relevant doses had a 55% confirmed response rate in 20 gynecologic cancer patients.

  Stock Titan · Oct 24, 2:30 AM EDT

• Certain Restricted Share Units of Immatics N.V. are subject to a Lock-Up Agreement Ending on 24-OCT-2026.

  www.marketscreener.com · Oct 23, 8:22 PM EDT

• Immatics N.V. Estimates – NASDAQ:IMTX

  TradingView · Oct 23, 10:52 AM EDT

• Immatics and 4 More Stocks See Action From Activist Investors

  Yahoo Finance · Sep 4, 6:59 PM EDT

• Immatics Announces $150 Million Underwritten Offering

  Yahoo Finance · Aug 25, 7:00 AM EDT

Immatics N.V. key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KFORM 6-K2026-10-26
• 6-KFORM 6-K2026-10-23
• 6-K6-K2026-08-26
• 6-K6-K2026-08-18
• 6-KFORM 6-K2026-06-18
• 6-KFORM 6-K2026-06-02
• 6-KFORM 6-K2026-06-01
• 6-K6-K2026-05-12
• 6-KFORM 6-K2026-04-21
• 6-KFORM 6-K2026-04-17
• 20-F20-F2026-03-05
• 6-KFORM 6-K2026-03-05

About Immatics N.V.

Ticker

IMTX (Nasdaq)

Industry

Biological Products, (No Diagnostic Substances)

Headquarters

Tubingen, Germany

Incorporated in

Netherlands

Fiscal year end

December 31

SEC CIK

1809196

Former names

Immatics B.V.

Frequently asked questions